Julie L. Wilsbacher

Statistics

Publications

Citations

3.3K

H-Index

Active since

1998

Affiliations

The University of Texas Southwestern Medical Center(Current)

Abbott Fund

Harvard University

AbbVie (United States)

Abbott (United States)

Julie L. Wilsbacher is an author at The University of Texas Southwestern Medical Center specializing in life sciences, signal transduction, and cell signaling.

ORCID

Publications per year

1998–2018

Publications

Phosphorylation of the MAP Kinase ERK2 Promotes Its Homodimerization and Nuclear Translocation

Andrei Khokhlatchev, Bertram Canagarajah, Julie L. Wilsbacher et al. · Cell · 1998 · 678 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

WNK1, a Novel Mammalian Serine/Threonine Protein Kinase Lacking the Catalytic Lysine in Subdomain II

Bing-e Xu, Jessie M. English, Julie L. Wilsbacher et al. · Journal of Biological Chemistry · 2000 · 536 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors

Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez et al. · Molecular Cancer Research · 2015 · 267 citations

Medicine, Oncology, Pharmacology +17

PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

Todd A. Hopkins, William B. Ainsworth, Paul A. Ellis et al. · Molecular Cancer Research · 2018 · 256 citations

Medicine, Oncology, Pharmacology +13

Vav GEFs are required for β2 integrin-dependent functions of neutrophils

M. Angelica Martinez Gakidis, Xavier Culleré, Timothy S. Olson et al. · The Journal of Cell Biology · 2004 · 221 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–5 of 26